569 related articles for article (PubMed ID: 30924862)
1. Exposure to a Healthy Gut Microbiome Protects Against Reproductive and Metabolic Dysregulation in a PCOS Mouse Model.
Torres PJ; Ho BS; Arroyo P; Sau L; Chen A; Kelley ST; Thackray VG
Endocrinology; 2019 May; 160(5):1193-1204. PubMed ID: 30924862
[TBL] [Abstract][Full Text] [Related]
2. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
[TBL] [Abstract][Full Text] [Related]
3. Letrozole treatment of adult female mice results in a similar reproductive phenotype but distinct changes in metabolism and the gut microbiome compared to pubertal mice.
Torres PJ; Skarra DV; Ho BS; Sau L; Anvar AR; Kelley ST; Thackray VG
BMC Microbiol; 2019 Mar; 19(1):57. PubMed ID: 30871463
[TBL] [Abstract][Full Text] [Related]
4. The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome.
Kelley ST; Skarra DV; Rivera AJ; Thackray VG
PLoS One; 2016; 11(1):e0146509. PubMed ID: 26731268
[TBL] [Abstract][Full Text] [Related]
5. Gut Metabolites Are More Predictive of Disease and Cohoused States than Gut Bacterial Features in a Polycystic Ovary Syndrome-Like Mouse Model.
Ho B; Ryback D; Benson B; Mason CN; Torres PJ; Quinn RA; Thackray VG; Kelley ST
mSystems; 2021 Oct; 6(5):e0114920. PubMed ID: 34519532
[TBL] [Abstract][Full Text] [Related]
6. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
7. Depletion of gut microbiota influents glucose metabolism and hyperandrogenism traits of mice with PCOS induced by letrozole.
Li Y; Zhu Y; Li D; Liu W; Zhang Y; Liu W; Zhang C; Tao T
Front Endocrinol (Lausanne); 2023; 14():1265152. PubMed ID: 37929036
[TBL] [Abstract][Full Text] [Related]
8. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
Ryan GE; Malik S; Mellon PL
Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
[TBL] [Abstract][Full Text] [Related]
9. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota.
He Y; Wang Q; Li X; Wang G; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jun; 11(6):5192-5204. PubMed ID: 32441726
[TBL] [Abstract][Full Text] [Related]
10. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Leber B; Horvath A; Pieber TR; Gorkiewicz G; Stadlbauer V; Obermayer-Pietsch B
PLoS One; 2017; 12(1):e0168390. PubMed ID: 28045919
[TBL] [Abstract][Full Text] [Related]
11. Association between Polycystic Ovary Syndrome and Gut Microbiota.
Guo Y; Qi Y; Yang X; Zhao L; Wen S; Liu Y; Tang L
PLoS One; 2016; 11(4):e0153196. PubMed ID: 27093642
[TBL] [Abstract][Full Text] [Related]
12. Metabolic dysregulation and gut dysbiosis linked to hyperandrogenism in female mice.
Chen A; Handzel A; Sau L; Cui L; Kelley ST; Thackray VG
Endocrinol Diabetes Metab; 2024 Jan; 7(1):e443. PubMed ID: 37872876
[TBL] [Abstract][Full Text] [Related]
13. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
[TBL] [Abstract][Full Text] [Related]
14. Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice.
Anima B; Gurusubramanian G; Roy VK
Cytokine; 2024 Jul; 179():156639. PubMed ID: 38733946
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.
Torres PJ; Siakowska M; Banaszewska B; Pawelczyk L; Duleba AJ; Kelley ST; Thackray VG
J Clin Endocrinol Metab; 2018 Apr; 103(4):1502-1511. PubMed ID: 29370410
[TBL] [Abstract][Full Text] [Related]
16. Sex, Microbes, and Polycystic Ovary Syndrome.
Thackray VG
Trends Endocrinol Metab; 2019 Jan; 30(1):54-65. PubMed ID: 30503354
[TBL] [Abstract][Full Text] [Related]
17. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.
Zhang H; Zheng L; Li C; Jing J; Li Z; Sun S; Xue T; Zhang K; Xue M; Cao C; Ouyang L; Qian Z; Xu R; He Z; Ma R; Chen L; Yao B
J Ovarian Res; 2023 Jul; 16(1):138. PubMed ID: 37443082
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype.
Wang L; Zhou J; Gober HJ; Leung WT; Huang Z; Pan X; Li C; Zhang N; Wang L
Biomed Pharmacother; 2021 Jan; 133():110958. PubMed ID: 33171400
[TBL] [Abstract][Full Text] [Related]
19. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
20. Temporal relationship between alterations in the gut microbiome and the development of polycystic ovary syndrome-like phenotypes in prenatally androgenized female mice.
Kusamoto A; Harada M; Azhary JMK; Kunitomi C; Nose E; Koike H; Xu Z; Urata Y; Kaku T; Takahashi N; Wada-Hiraike O; Hirota Y; Koga K; Fujii T; Osuga Y
FASEB J; 2021 Nov; 35(11):e21971. PubMed ID: 34653284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]